Generic name |
Strength / form / brand name | |
tobramycin solution (for inhalation) |
300 mg; 5 mL - TOBI® | |
tobramycin inhalation (powder) | 28 mg capsule, for use with – TOBI® Podhaler® only |
Special Authority criteria |
Approval period |
---|---|
For the cyclic treatment of chronic pulmonary Pseudomonas aeruginosa infections in patients with moderate to severe cystic fibrosis AND who do not tolerate injectable forms of tobramycin to manage inhalation issues. |
Indefinite |